The drug’s foundation is a tiny but potent antibody that can block the virus from infecting cells. The drug, called Ab8, has been effective in preventing and treating covid-19 in mice and hamsters. Human clinical trials could begin in early 2021.
At a news conference Tuesday, UPMC officials said the drug will be especially helpful to vulnerable patients who wouldn’t respond as well to a vaccine, such as the elderly or those with compromised immune systems.
Source: Pittsburgh researchers unveil new drug that could treat and prevent covid-19 | TribLIVE.com
